2013-12-19 07:59:45 - Nearly five percent of UAE population suffers from the rare disease, a key topic at Arab Health Congress 2014
Dubai, UAE: Nearly five percent of the UAE population suffers from Pulmonary Hypertension disease , high blood pressure in the arteries of the lungs that can lead to heart failure, blood clots and internal bleeding. The figure, in line with global numbers, highlights the need for effective surveillance of the disease epidemiology in the region, as well as public awareness campaigns and new treatment facilities.
With more than one billion people around the world who suffer from chronic respiratory diseases including Pulmonary Hypertension , there are a number of known symptoms including breathlessness, dizziness, feeling faint, swelling of the feet or ankles, and chest pain. Currently there is no one-off test available across the globe to diagnose pulmonary hypertension and people
often require a number of tests before an accurate diagnosis can be made.
The Middle East is, however, at the center of innovative technology providing treatment to residents of the UAE, with the recent inauguration of the first specialist treatment unit in the country, and provides a skilled team of physicians, nurses, technicians and disease specialists.
Dr. Bassam Mahboub, Head of Department Respiratory Disease, Allergy and Sleep Medicine, Rashid Hospital, Dubai, UAE, said: “Pulmonary hypertension is a chronic progressive disease that has a worse prognosis than many known malignancy. However, in the last decade, there has been a tremendous improvement in understanding the pathology of this disease which has led to breakthroughs in the medical treatment. The last year only has witnessed the approval of two new drugs. The severity and complexity of this illness require that these patients should only be treated by experienced centers.”
Raising awareness regionally and internationally is the Saudi Advisory Group for Pulmonary Hypertension (SAPH) who recognises the lack of awareness amongst local physicians and caregivers. The group aims to ease patient suffering through providing support, education and treatment, and continue to focus on the importance of research.
Mr. Majdy Idrees, President, SAPH, KSA, said: “SAPH is the only Pulmonary Hypertension specialised body in the Arab world and is currently addressing issues related to the education and training of healthcare professionals in the Pulmonary Hypertension field. SAPH has extensively involved in improving the awareness of Pulmonary Hypertension among both patients and physicians and has succeeded to link the international and local experts through collaboration with many international societies.”
Pulmonary Hypertension will be discussed at the fourth Respiratory, Critical Care and Sleep Diseases Conference at Arab Health Congress to be held in January in Dubai, UAE, which will look at the latest information on the diagnosis, management and treatment of the disease.
Note to Editors
About Arab Health Exhibition & Congress
Arab Health Exhibition & Congress is the largest healthcare event in the Middle East. Established 39 years ago, Arab Health provides a platform for the world’s leading manufacturers, wholesalers and distributors to meet the medical and scientific community in the Middle East and subcontinent. Arab Health, organised by Informa Life Sciences Exhibitions, takes place from 27-30 January 2014 at the Dubai International Convention & Exhibition Centre. With more than 3900 exhibiting companies from 63 countries and 19 healthcare conferences with an estimated 9000 delegates, Arab Health is a much anticipated addition to the 2014 medical event calendar.
About Saudi Advisory Group for Pulmonary Hypertension (SAPH):
For press enquires please contact:
Tel: +971 4 3344930